Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Mar 1, 2026DOI: 10.1016/j.cardfail.2026.02.035Journal ArticleJCF
Written by: Olives NguyenJack WiedrickDaniele MasseraElizabeth AdlesteinSumar FrejatMatteo CastrichiniSaid AlsidawiJohn R GiudicessiJeffrey B GeskeRichard T CarrickJose MadrazoNicole DelliseMark A ZenkerThomas A BoyleNosheen RezaAnjali Tiku OwensDavid S FrankelPrabhjot HundalJamil TajikPatrycja GalazkaMyra LewontinMichael AyersTimothy WongMichael FlanaganSumeet Singh MitterArjun KanwalOzlem BilenSarah BaghdadiHirak ShahJared KvapilPaola RoldanLoren BerenbomJill JesurumDenise TootillAlice Siqueira-BenzowMariko HarperDanish SalehLubna ChoudhuryIsabela ValentaMelissa LangDermot M PhelanDmitry PrizandNeal LakdawalaCarolyn Y HoLusha W LiangShepard D WeinerSririam RaviAhmed Sami AbuzaidMohammed MakkiyaJeremy S MarkowitzMark SherridAhmad Masri
Find these authors on Roon
NR
Dr. Nosheen Reza
Advanced Heart Failure · HUP
MA
Dr. Michael Ayers
General Cardiology · UVA Medical Center
AA
Dr. Ahmed Sami Abuzaid
General Cardiology · AHVI
Full abstract not available! Read the article on the external site for details.
AA
Dr. Ahmed Sami Abuzaid
Cardiology · General Non-Invasive CardiologyAlaska Heart and Vascular InstituteahmedabuzaidAnchorage, AK, USA